18 October 2022

Colm Nestor, associate professor in the Department of Biomedical and Clinical Sciences (BKV), has been awarded a Consolidator Grant from the European Research Council (ERC) of approximately SEK 22 million over the next 5 years. The funding will be used to research sex bias in human disease.

Colm Nestor.Colm Nestor. Photo credit John Karlsson

Although the development of the immune system is identical in men and women, autoimmune diseases such as multiple sclerosis and SLE are far more common in women. In contrast, women have better resistance to both viral and bacterial infections than men. For example, men are three times more likely to require treatment in intensive care following SARS-CoV-2 infection than women. This ‘sex bias’ in COVID-19 severity and mortality has further highlighted the importance of sex as a contributor to disease.

Whereas men have one X chromosome (which they inherit from their mother), women have two X chromosomes, one inherited from their mother and one inherited from their father. To balance the number of copies of X chromosome genes between men and women, each cell in a woman switches off one of its X chromosomes, a phenomenon called ‘X inactivation’. However, the process of X inactivation is not perfect, and some genes on the inactive X chromosome remain switched on. Consequently, female cells have twice as many of these so-called ‘escape’ genes, many of which perform important roles in the immune system. The Nestor group will investigate whether these genes cause the sex bias observed in many immune-related diseases in women.

The project, called XX-Health, will analyse human blood samples in biobanks held at Linköping University Hospital to assess how X-inactivation patterns are associated with immune-related disorders in women. Further, the project will analyse how individual genes on each X chromosome affect the biology of T cells, an important type of immune cell involved in both fighting infection and causing autoimmune disorders.

“I’m thrilled to receive this grant, which is built on the hard work and innovation of all the researchers in my group. The scale of this financing will allow us to tackle this important, yet poorly understood, part of human genetics with state-of-the-art next-generation sequencing and gene-manipulation technologies. Although the project is technically highly challenging, we are confident we will not only make discoveries about the enigmatic process of X inactivation but also understand how this process contributes to human disease,” says Colm Nestor.

Latest news from LiU

A man in formal wear on stage

Professors and award winners get their own Academic Ceremony

New professors will be inaugurated and award winners and Alumni of the Year will be celebrated at the Academic Ceremony on 10 October. Linköping University is growing, and as of this year two Academic Ceremonies will be held.

CMIV's MR scanner Philips 3T

From inside the body to the future of healthcare – 25 years of CMIV

25 years ago, an idea was born in Linköping: to unite research, healthcare, and industry in developing the medical tools of the future. Two years later, that vision became reality when CMIV was founded and its operations began.

Erik Sandberg.

Smart logistics can set the circular economy in motion

Many companies want to invest more in recycling and reuse as part of their business strategy – but the challenge is making it profitable. One important, yet often overlooked, factor is logistics. That is the view of researcher Erik Sandberg at LiU.

More about the research